Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · IEX Real-Time Price · USD
9.66
+0.04 (0.42%)
At close: Jul 19, 2024, 12:00 AM
9.73
+0.07 (0.72%)
Pre-market: Jul 22, 2024, 8:42 AM EDT
Rigel Pharmaceuticals Employees
Rigel Pharmaceuticals had 147 employees as of December 31, 2023. The number of employees decreased by 8 or -5.16% compared to the previous year.
Employees
147
Change (1Y)
-8
Growth (1Y)
-5.16%
Revenue / Employee
$818,680
Profits / Employee
-$134,707
Market Cap
169.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
OrganiGram Holdings | 984 |
Repare Therapeutics | 179 |
Adverum Biotechnologies | 121 |
MediWound | 100 |
Syros Pharmaceuticals | 68 |
Acumen Pharmaceuticals | 52 |
Fennec Pharmaceuticals | 29 |
Atossa Therapeutics | 12 |
RIGL News
- 10 days ago - Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 24 days ago - Optime Care Announces Enhanced Partnership with Rigel Pharmaceuticals for GAVRETO® Patients - Business Wire
- 27 days ago - Rigel Announces Reverse Stock Split - PRNewsWire
- 27 days ago - Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application - PRNewsWire
- 5 weeks ago - Rigel Announces Five Presentations at the EHA2024 Hybrid Congress - PRNewsWire
- 7 weeks ago - Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting - PRNewsWire
- 7 weeks ago - Rigel to Present at the Jefferies Global Healthcare Conference - PRNewsWire
- 2 months ago - Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress - PRNewsWire